Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity

Cancer Research

Volumn 61, Issue 2, 2001, Pages 577-581

  Mitsiades, Nicholas ^a   Yu, Wei Hsuan ^a   Poulaki, Vassiliki ^b   Tsokos, Maria ^b   Stamenkovic, Ivan ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN; FAS ANTIBODY; GELATINASE A; GELATINASE B; MATRILYSIN;

APOPTOSIS; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; EWING SARCOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE;

ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; COLONIC NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FAS LIGAND PROTEIN; HUMANS; HYDROLYSIS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 7; MEMBRANE GLYCOPROTEINS; SARCOMA, EWING'S; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0035863471     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. P-glycoprotein in adult solid tumors, Expression and prognostic significance
2. Apoptosis in the pathogenesis and treatment of disease
3. Apoptosis induced by anticancer drugs
4. Alterations of Fas (Apo-1/CD95) gene in non-small cell lung cancer
5. Fas and Fas ligand interactions suppress melanoma lung metastasis
6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand
7. Apoptosis signaling by death receptors
8. FADD a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
9. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
10. A role for CD95 ligand in preventing graft rejection
11. Melanoma cell expression of Fas(APO-1/CD95) ligand: Implications for tumor immune escape
12. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
13. Metalloproteinase-mediated release of human Fas ligand
14. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis
15. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity
16. Downregulation of Fas ligand by shedding
17. Changing views of the role of matrix metallopmteinases in metastasis
18. Activation mechanisms of matrix metalloproteinases
19. The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application
20. Molecular insights into cancer invasion: Strategies for prevention and intervention
21. Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors
22. CD44 is the principal cell surface receptor for hyaluronate
23. Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7)
24. FasL induction and Fas upregulation by anticancer drugs
25. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells
26. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
27. Molecular ordering of apoptosis induced by anticancer drugs in neuroblastoma cells
28. Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells
29. Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
30. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas
31. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma
32. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo